Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.
Inovio Pharmaceuticals Inc. (INO) shares fell 4.41% to $1.30 on Friday, underperforming against competitors like Johnson & Johnson and Pfizer. The NASDAQ Composite Index dropped 1.54%, while Inovio's stock remains 56.36% below its 52-week high of $2.98. Trading volume was 1.9 million, below the 50-day average of 2.7 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments